Silver P J, Stull J T
Mol Pharmacol. 1983 May;23(3):665-70.
The activities of phosphorylase kinase and myosin light-chain kinase are regulated by Ca2+ binding to calmodulin. However, differences in the activation properties of the purified enzymes are apparent, since calmodulin binds to phosphorylase kinase in the absence of Ca2+ whereas prior formation of a Ca2+ . calmodulin complex is necessary for calmodulin to bind to and activate myosin light chain kinase. Since the phenothiazines have been implicated as anticalmodulin drugs and inhibit contractile activity in smooth muscle, we examined the effects of the phenothiazine, fluphenazine, on isometric tension development and phosphorylation of phosphorylase and the phosphorylatable light chain (P-light chain) of myosin in intact bovine tracheal smooth muscle. Preincubation with 50 microM fluphenazine for 5 min inhibited the maximal rate and extent of isometric tension development and P-light chain phosphorylation in the presence of 60 mM KCl. Application of fluphenazine after tension and the phosphate content of the P-light chain had reached steady-state levels in response to 60 mM KCl produced little relaxation or dephosphorylation of the P-light chain. KCl-mediated phosphorylase a formation was not inhibited by preincubation with fluphenazine for 5 min. However, long periods of preincubation (30-60 min) produced significant inhibition of phosphorylase a formation and proportionally greater inhibition of tension and P-light chain phosphorylation. Since phosphorylase a formation was not inhibited during short-term preincubation with fluphenazine, KCl-dependent increases in the concentration of free intracellular Ca2+ may not have been affected. Moreover, since both isometric tension development and P-light chain phosphorylation were attenuated in a parallel manner, inhibition of contractile activity in intact smooth muscle by anticalmodulin agents may be directly related to inhibition of P-light chain phosphorylation.
磷酸化酶激酶和肌球蛋白轻链激酶的活性受钙离子与钙调蛋白结合的调节。然而,纯化酶的激活特性存在明显差异,因为在没有钙离子的情况下钙调蛋白就能与磷酸化酶激酶结合,而钙调蛋白要与肌球蛋白轻链激酶结合并激活它,则必须预先形成钙离子 - 钙调蛋白复合物。由于吩噻嗪类药物被认为是抗钙调蛋白药物且能抑制平滑肌的收缩活性,我们研究了吩噻嗪类药物氟奋乃静对完整牛气管平滑肌等长张力发展以及磷酸化酶和肌球蛋白可磷酸化轻链(P - 轻链)磷酸化的影响。在60 mM氯化钾存在的情况下,用50 μM氟奋乃静预孵育5分钟可抑制等长张力发展的最大速率和程度以及P - 轻链的磷酸化。在60 mM氯化钾作用下,张力和P - 轻链的磷酸盐含量达到稳态水平后应用氟奋乃静,几乎不会使P - 轻链松弛或去磷酸化。用氟奋乃静预孵育5分钟不会抑制氯化钾介导的磷酸化酶a的形成。然而,长时间预孵育(30 - 60分钟)会显著抑制磷酸化酶a的形成,并且对等长张力和P - 轻链磷酸化的抑制作用更大。由于在与氟奋乃静短期预孵育期间磷酸化酶a的形成未受抑制,氯化钾依赖的细胞内游离钙离子浓度增加可能未受影响。此外,由于等长张力发展和P - 轻链磷酸化均以平行方式减弱,抗钙调蛋白药物对完整平滑肌收缩活性的抑制可能与P - 轻链磷酸化的抑制直接相关。